Melrose CEO Peter Dilnot has overtaken AstraZeneca’s Pascal Soriot as the UK’s highest-paid FTSE 100 boss after a £45m payout, fuelling fresh debate over executive pay gaps.

In a report released today, Justin Smith from Bernstein maintained a Buy rating on GlaxoSmithKline, with a price target of £21.70. The company’s shares closed today at p1,373.00. Take advantage of ...

Detailed price information for Grifols S.A. ADR (GRFS-Q) from The Globe and Mail including charting and trades.

The number of significant shareholder protests has more than doubled so far this year compared with a year ago, with 11 FTSE ...

The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.

The growing healthcare burden posed by hepatocellular carcinoma, the most common subtype of liver cancer, has prompted the ...

A new market analysis forecasts significant growth for the global pneumococcal vaccines market, with the industry projected ...

Delhi Police have busted a medicine racket making counterfeit life-saving drugs using the names of big pharma companies such ...

Pfizer is the closest company to producing a Lyme disease vaccine. Experts are concerned that vaccine skepticism could stand in its way.

The global cervical cancer treatment market is poised for significant expansion, with a new market analysis projecting its value to grow from an estimated USD 9.2 billion in 2025 to USD 15.9 billion ...

U.S. District Judge Paul Diamond, of the Eastern District of Pennsylvania, said he was considering sanctions against Steve ...